Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.6750
+0.0290 (4.49%)
Apr 17, 2025, 4:00 PM EDT - Market closed
CTOR's stock price has decreased by -93.92% in the past year and price targets may not have had time to catch up.
Citius Oncology Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$4.50
Upside
+566.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +344.44% | Nov 27, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +788.89% | Aug 13, 2024 |